SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-005423
Filing Date
2014-01-08
Accepted
2014-01-08 16:21:33
Documents
4
Period of Report
2014-01-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d656131d8k.htm 8-K 15458
2 EX-99.1 d656131dex991.htm EX-99.1 5507
3 EX-99.2 d656131dex992.htm EX-99.2 8037
4 GRAPHIC g656131img1.jpg GRAPHIC 11407
  Complete submission text file 0001193125-14-005423.txt   46161
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 14516664
SIC: 2835 In Vitro & In Vivo Diagnostic Substances